Pfizer’s BA.4/5-Adapted Comirnaty Grabs Special Approval in Japan

October 6, 2022
The Ministry of Health, Labor and Welfare (MHLW) on October 5 granted a special approval to Pfizer’s bivalent COVID-19 vaccine Comirnaty RTU tailored to the BA.4/BA.5 Omicron subvariants. The green light was given as a partial modification to the previous...read more